{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:25:51Z","timestamp":1792891551606,"version":"4.5.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frontiers: University of Kansas Clinical"},{"name":"Translational Sciences Institute","award":["KL2TR002367"],"award-info":[{"award-number":["KL2TR002367"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Despite high rates of opioid therapy, evidence about the risk of preventable opioid harms among cancer survivors is underdeveloped. Our objective was to estimate the odds of opioid use disorder (OUD) and overdose following breast, colorectal, or prostate cancer diagnosis among Medicare beneficiaries.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study using 2007-2014 Surveillance, Epidemiology, and End Results-Medicare data for cancer survivors with a first cancer diagnosis of stage 0-III breast, colorectal, or prostate cancer at age 66-89 years between 2008 and 2013. Cancer survivors were matched to up to 2 noncancer controls on age, sex, and Surveillance, Epidemiology, and End Results region. Using Firth logistic regression, we estimated adjusted 1-year odds of OUD or nonfatal opioid overdose associated with a cancer diagnosis. We also estimated adjusted odds of OUD and overdose separately and by cancer stage, prior opioid use, and follow-up time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 69\u2009889 cancer survivors and 125\u2009007 controls, the unadjusted rates of OUD or nonfatal overdose were 25.2, 27.1, 38.9, and 12.4 events per 10\u2009000 patients in the noncancer, breast, colorectal, and prostate samples, respectively. There was no association between cancer and OUD. Colorectal survivors had 2.3 times higher odds of opioid overdose compared with matched controls (adjusted odds ratio\u2009=\u20092.33, 95% confidence interval \u2009=\u20091.49 to 3.67). Additionally, overdose risk was greater in those with more advanced disease, no prior opioid use, and preexisting mental health conditions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Opioid overdose was a rare, but statistically significant, outcome following stage II-III colorectal cancer diagnosis, particularly among previously opioid-na\u00efve patients. These patients may require heightened screening and intervention to prevent inadvertent adverse opioid harms.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djaa122","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T03:37:17Z","timestamp":1597203437000},"page":"425-433","source":"Crossref","is-referenced-by-count":15,"title":["Opioid Use Disorder and Overdose in Older Adults With Breast, Colorectal, or Prostate Cancer"],"prefix":"10.1093","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-8256","authenticated-orcid":false,"given":"Andrew W","family":"Roberts","sequence":"first","affiliation":[{"name":"Department of Population Health, University of Kansas Medical Center (KUMC), University of Kansas Cancer Center, Kansas City, KS, USA"},{"name":"Department of Anesthesiology, University of Kansas Medical Center (KUMC), University of Kansas Cancer Center, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8612-3807","authenticated-orcid":false,"given":"Samantha","family":"Eiffert","sequence":"additional","affiliation":[{"name":"Department of Population Health, University of Kansas Medical Center (KUMC), University of Kansas Cancer Center, Kansas City, KS, USA"},{"name":"Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1474-7095","authenticated-orcid":false,"given":"Elizabeth M","family":"Wulff-Burchfield","sequence":"additional","affiliation":[{"name":"Divisions of Medical Oncology and Palliative Medicine, Department of Internal Medicine, KUMC, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie B","family":"Dusetzina","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon K","family":"Check","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine; Duke Cancer Institute, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"2021040620070981600_djaa122-B1"},{"key":"2021040620070981600_djaa122-B2"},{"issue":"5152","key":"2021040620070981600_djaa122-B3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths - United States, 2013-2017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"2021040620070981600_djaa122-B4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMsa1610524","article-title":"Opioid-prescribing patterns of emergency physicians and risk of long-term use","volume":"376","author":"Barnett","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"2021040620070981600_djaa122-B5","doi-asserted-by":"crossref","first-page":"e170504","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"issue":"2","key":"2021040620070981600_djaa122-B6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M18-2864","article-title":"Patterns of opioid administration among opioid-naive inpatients and associations with postdischarge opioid use: a cohort study","volume":"171","author":"Donohue","year":"2019","journal-title":"Ann Intern Med"},{"issue":"36","key":"2021040620070981600_djaa122-B7","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","article-title":"New persistent opioid use among patients with cancer after curative-intent surgery","volume":"35","author":"Lee","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021040620070981600_djaa122-B8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cncr.32593","article-title":"New-onset persistent opioid use following breast cancer treatment in older adult women","volume":"126","author":"Roberts","year":"2020","journal-title":"Cancer"},{"issue":"12","key":"2021040620070981600_djaa122-B9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.18.00938","article-title":"Trends in opioid use among older survivors of colorectal, lung, and breast cancers","volume":"37","author":"Salz","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"2021040620070981600_djaa122-B10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaoncol.2019.0042","article-title":"US National trends in opioid-related hospitalizations among patients with cancer","volume":"5","author":"Chua","year":"2019","journal-title":"JAMA Oncol"},{"key":"2021040620070981600_djaa122-B11","doi-asserted-by":"crossref","first-page":"e18830","DOI":"10.1200\/JCO.2018.36.15_suppl.e18830","article-title":"Inpatient utilization of naloxone at a tertiary cancer center","volume":"36(15_suppl","author":"Dalal","year":"2018","journal-title":"J Clin Oncol"},{"key":"2021040620070981600_djaa122-B12","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djz233","article-title":"Emergency department visits for opioid overdoses among patients with cancer","author":"Jairam","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"2021040620070981600_djaa122-B13","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain: a systematic review and meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"2021040620070981600_djaa122-B14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","article-title":"Anticipating the \u201cSilver Tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"25","author":"Bluethmann","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2021040620070981600_djaa122-B15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2021040620070981600_djaa122-B16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jpainsymman.2017.07.017","article-title":"Opioid prescribing among cancer and non-cancer patients: time trend analysis in the elderly using administrative data","volume":"54","author":"Barbera","year":"2017","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"2021040620070981600_djaa122-B17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clon.2009.12.002","article-title":"Frequency of opioid use in a population of cancer patients during the trajectory of the disease","volume":"22","author":"Jarlbaek","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"21","key":"2021040620070981600_djaa122-B18","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/cncr.30839","article-title":"Cancer survivorship and opioid prescribing rates: a population-based matched cohort study among individuals with and without a history of cancer","volume":"123","author":"Sutradhar","year":"2017","journal-title":"Cancer"},{"issue":"11","key":"2021040620070981600_djaa122-B19","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.6004\/jnccn.2016.0151","article-title":"Psychotropic and opioid medication use in older patients with breast cancer across the care trajectory: a population-based cohort study","volume":"14","author":"Syrowatka","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"2021040620070981600_djaa122-B20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-017-4348-8","article-title":"Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens","volume":"165","author":"Tan","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"2021040620070981600_djaa122-B21","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1200\/JCO.2013.52.4629","article-title":"Pain in cancer survivors","volume":"32","author":"Glare","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"2021040620070981600_djaa122-B22","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"2021040620070981600_djaa122-B23","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jamaoncol.2019.1439","article-title":"Prevalence of chronic pain and high-impact chronic pain in cancer survivors in the United States","volume":"5","author":"Jiang","year":"2019","journal-title":"JAMA Oncol"},{"issue":"14","key":"2021040620070981600_djaa122-B24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/archinternmed.2009.179","article-title":"Psychological distress in long-term survivors of adult-onset cancer: results from a national survey","volume":"169","author":"Hoffman","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"2021040620070981600_djaa122-B25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s11764-015-0438-y","article-title":"Depression and quality of life before and after breast cancer diagnosis in older women from the Women's Health Initiative","volume":"9","author":"Jones","year":"2015","journal-title":"J Cancer Surviv"},{"issue":"8","key":"2021040620070981600_djaa122-B26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1470-2045(13)70244-4","article-title":"Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis","volume":"14","author":"Mitchell","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"2021040620070981600_djaa122-B27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.canep.2014.10.002","article-title":"Current depression among adult cancer survivors: findings from the 2010 Behavioral Risk Factor Surveillance System","volume":"38","author":"Zhao","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"2021040620070981600_djaa122-B28","article-title":"SEER cancer statistics review, 1975-2015","author":"Noone","year":"2018","journal-title":"National Cancer Institute"},{"key":"2021040620070981600_djaa122-B29"},{"key":"2021040620070981600_djaa122-B30"},{"issue":"9","key":"2021040620070981600_djaa122-B31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1200\/JCO.2012.43.0272","article-title":"Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls","volume":"31","author":"Snyder","year":"2013","journal-title":"J Clin Oncol"},{"key":"2021040620070981600_djaa122-B32"},{"issue":"3","key":"2021040620070981600_djaa122-B33","doi-asserted-by":"crossref","first-page":"e190968","DOI":"10.1001\/jamanetworkopen.2019.0968","article-title":"Evaluation of machine-learning algorithms for predicting opioid overdose risk among Medicare beneficiaries with opioid prescriptions","volume":"2","author":"Lo-Ciganic","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2021040620070981600_djaa122-B34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.annepidem.2007.03.011","article-title":"A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients","volume":"17","author":"Klabunde","year":"2007","journal-title":"Ann Epidemiol"},{"key":"2021040620070981600_djaa122-B35","year":"2019"},{"issue":"25","key":"2021040620070981600_djaa122-B36","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"2021040620070981600_djaa122-B37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"issue":"7172","key":"2021040620070981600_djaa122-B38","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/bmj.317.7172.1572","article-title":"Survival probabilities (the Kaplan-Meier method)","volume":"317","author":"Bland","year":"1998","journal-title":"BMJ"},{"issue":"7447","key":"2021040620070981600_djaa122-B39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","article-title":"The logrank test","volume":"328","author":"Bland","year":"2004","journal-title":"BMJ"},{"issue":"13","key":"2021040620070981600_djaa122-B40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"2021040620070981600_djaa122-B41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/oxfordjournals.aje.a009095","article-title":"Ability of Medicare claims data and cancer registries to identify cancer cases and treatment","volume":"145","author":"McClish","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2021040620070981600_djaa122-B42","first-page":"1","article-title":"Predictors and prevalence of pain and its management in four regional cancer hospitals in India","volume":"4","author":"Doyle","year":"2018","journal-title":"J Glob Oncol"},{"issue":"15","key":"2021040620070981600_djaa122-B43","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1200\/JCO.2017.76.0355","article-title":"Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: disease-free survival results from a randomized, open-label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial","volume":"36","author":"Andre","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"2021040620070981600_djaa122-B44","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","article-title":"Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V","volume":"34","author":"Colleoni","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"2021040620070981600_djaa122-B45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","article-title":"Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021040620070981600_djaa122-B46"},{"issue":"5","key":"2021040620070981600_djaa122-B47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.2019.7988","article-title":"Naloxone co-prescribing to patients receiving prescription opioids in the Medicare Part D Program, United States, 2016-2017","volume":"322","author":"Jones","year":"2019","journal-title":"JAMA"},{"key":"2021040620070981600_djaa122-B48"},{"issue":"1","key":"2021040620070981600_djaa122-B49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJMra1802148","article-title":"Understanding links among opioid use, overdose, and suicide","volume":"380","author":"Bohnert","year":"2019","journal-title":"N Engl J Med"},{"issue":"17","key":"2021040620070981600_djaa122-B50","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMp1801417","article-title":"Suicide: a silent contributor to opioid-overdose deaths","volume":"378","author":"Oquendo","year":"2018","journal-title":"N Engl J Med"},{"issue":"14","key":"2021040620070981600_djaa122-B51","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1110307","article-title":"Suicide and cardiovascular death after a cancer diagnosis","volume":"366","author":"Fang","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"2021040620070981600_djaa122-B52","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/cncr.31303","article-title":"Cancer pain management and the opioid crisis in America: how to preserve hard-earned gains in improving the quality of cancer pain management","volume":"124","author":"Paice","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"2021040620070981600_djaa122-B53","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jpainsymman.2019.01.013","article-title":"Cancer and opioids: patient experiences with stigma (COPES)-a pilot study","volume":"57","author":"Bulls","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2021040620070981600_djaa122-B54"},{"issue":"293","key":"2021040620070981600_djaa122-B55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/01621459.1961.10482090","article-title":"Multiple comparisons among means","volume":"56","author":"Dunn","year":"1961","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"2021040620070981600_djaa122-B56","doi-asserted-by":"crossref","first-page":"e0116774","DOI":"10.1371\/journal.pone.0116774","article-title":"Statistical inference methods for 2 crossing survival curves: a comparison of methods","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaa122\/34693567\/djaa122.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/113\/4\/425\/36908673\/djaa122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/113\/4\/425\/36908673\/djaa122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T22:49:25Z","timestamp":1617749365000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/113\/4\/425\/5893484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,8,17]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaa122","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,8,17]]}}}